Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics--results from a German observational study

January 2011
BMC Psychiatry;2011, Vol. 11 Issue 1, p173
Academic Journal
The article focuses on an observational study, which explores the prevalence of metabolic syndrome (MetS) in adult in- and outpatients with untreated or treated schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics. The background, methods, results, and conclusions of the study, are discussed.


Related Articles

  • Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results.  // BMC Psychiatry;2011, Vol. 11 Issue 1, p167 

    The article focuses on a study, which aims to assess the effectiveness outcomes in a real-world setting in schizophrenics initiating risperidone long-acting therapy (RLAT). The study was a 24-month, multicenter, prospective, longitudinal, observational study. It is concluded that improvements...

  • DURATION OF ILLNESS, SYMPTOMS AND FUNCTIONAL RECOVERY IN PATIENTS SUFFERING FROM SCHIZOPHRENIA. Nazar, Zahid; Rabbani, Fazle; Ali, Gohar; Zahoor, Nazish; Lawangeen, Sibtain; Awan, Naila Riaz // Journal of Pakistan Psychiatric Society;Jul-Dec2013, Vol. 10 Issue 2, p77 

    Objective: To assess the symptomatic and functional recovery with long duration of illness of schizophrenics at baseline and after at 5 years follow up Design: Descriptive observational study. Place and Duration of study: This study was conducted at department of Psychiatry Lady Reading Hospital...

  • Self-perception of quality of life in patients treated with antipsychotics. DIMA, Lorena; VASILE, Daniel; ROGOZEA, Liliana; ZIA-UL-HAQ, Muhammad; BUKHARI, Shazia Anwer; MOGA, Marius // Turkish Journal of Medical Sciences;2015, Vol. 45 Issue 4, p782 

    Background/aim: Despite extensive research, normal functionality remains problematic in patients with schizophrenia. Issues such as quality of life, subjective well-being, or psychosocial performance are currently objectives of interest. There are limited data collected prospectively on...

  • Bridging the science-to-service gap in schizophrenia care in the Netherlands: the Schizophrenia Quality Improvement Collaborative. Van Duin, Danielle; Franx, Gerdien; Van Wijngaarden, Bob; Van Der Gaag, Mark; Van Weeghel, Jaap; Slooff, Cees; Wensing, Michel // International Journal for Quality in Health Care;Dec2013, Vol. 25 Issue 6, p626 

    Objective Many patients with schizophrenia are not treated in line with evidence-based guidelines. This study examines the large-scale implementation of the National Multidisciplinary Guideline for schizophrenia in the Netherlands. Design Observational, prospective study, with repeated...

  • Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study. Srisurapanont, Manit; Likhitsathian, Surinporn; Boonyanaruthee, Vudhichai; Charnsilp, Chawanun; Jarusuraisin, Ngamwong // BMC Psychiatry;2007, Vol. 7, p14 

    Background: Not only the prevalence, but also the progress of metabolic abnormalities in schizophrenic patients is of importance for treatment planning and policy making. However, there have been very few prospective studies of metabolic disturbance in schizophrenic patients. This study aimed to...

  • The metabolic syndrome and schizophrenia: A comorbidity or an association? khalil, Rami Bou // Journal of Pharmacology & Pharmacotherapeutics;Jul-Sep2013, Vol. 4 Issue 3, p190 

    The article discusses the connection between the metabolic syndrome and schizophrenia. It states that the lifestyle of patients with schizophrenia is accompanied with the risk factors which may increase the risk of the development of metabolic syndrome. It also mentions that the risk of...

  • COMMENTARY. Smith, Shubulade // Evidence Based Mental Health;May2008, Vol. 11 Issue 2, p62 

    The article comments on the study "Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey," by J.M. Suvisaari and colleagues. The author notes that the study is a good working knowledge of the metabolic side effects of all antipsychotics...

  • Prevalence of metabolic syndrome and its association with depression in patients with schizophrenia. Sirijit Suttajit; Sutrak Pilakanta // Neuropsychiatric Disease & Treatment;2013, Vol. 9, p941 

    Purpose: To identify the point prevalence of metabolic syndrome in patients with schizophrenia and to evaluate the association between depressive symptoms and metabolic syndrome in patients with schizophrenia. Patients and methods: Metabolic syndrome was assessed based on an updated definition...

  • Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a doubleblind, randomized, open-label study. Wani, Rayees Ahmad; Dar, Mansoor Ahmad; Chandel, Rajesh Kumar; Rather, Yasir Hassan; Haq, Inaamul; Hussain, Arshad; Malla, Altaf Ahmad // Neuropsychiatric Disease & Treatment;2015, Vol. 11, p685 

    Background: Patients with schizophrenia suffer high rates of metabolic derangements on some antipsychotic medications that predispose them to cardiovascular diseases. Keeping this fact in mind, we planned this open-label study to see the effect on various metabolic parameters after switching...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics